The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Josep Rodés-Cabau

Showing 1-20 of 25 articles
Bioprosthetic valve fracture: haemodynamically effective but safe and clinically necessary?
Rodés-Cabau J, Alperi A
November 19, 2021 | 10.4244/EIJV17I10A135
Outcomes of transcatheter tricuspid valve intervention by right ventricular function: a multicentre propensity-matched analysis
Schlotter F, Miura M, Kresoja K, Alushi B, Alessandrini H, Attinger-Toller A, Besler C, Biasco L, Braun D, Brochet E, Connelly K, de Bruijn S, Denti P, Estevez-Loureiro R, Fam N, Gavazzoni M, Himbert D, Ho E, Juliard J, Kalbacher D, Kaple R, Kreidel F, Latib A, Lubos E, Ludwig S, Mehr M, Monivas V, Nazif T, Nickenig G, Pedrazzini G, Pozzoli A, Praz F, Puri R, Rodés-Cabau J, Rommel K, Schäfer U, Schofer J, Sievert H, Tang G, Thiele H, Unterhuber M, Vahanian A, von Bardeleben R, von Roeder M, Webb J, Weber M, Wild M, Windecker S, Zuber M, Hausleiter J, Maisano F, Leon M, Hahn R, Lauten A, Taramasso M, Lurz P
July 20, 2021 | 10.4244/EIJ-D-21-00191
Consolidating the BASILICA technique in TAVI patients at risk of coronary obstruction
Rodés-Cabau J, Ribeiro H
October 23, 2020 | 10.4244/EIJV16I8A114
Coronary interventions
Angiography-based quantitative flow ratio versus fractional flow reserve in patients with coronary artery disease and severe aortic stenosis
Mejía-Rentería H, Nombela-Franco L, Paradis J, Lunardi M, Lee J, Amat-Santos I, Veiga Fernandez G, Kalra A, Bansal E, de la Torre Hernandez J, Rodés-Cabau J, Ribichini F, Escaned J
July 17, 2020 | 10.4244/EIJ-D-19-01001
Interventions for heart failure
Interatrial shunt with the second-generation V-Wave system for patients with advanced chronic heart failure
Guimarães L, Bergeron S, Bernier M, Rodriguez-Gabella T, del Val D, Pibarot P, Eigler N, Abraham W, Rodés-Cabau J
March 20, 2020 | 10.4244/EIJ-D-19-00291
The Atrial Flow Regulator device: expanding the field of interatrial shunting for treating heart failure patients
Guimarães L, del Val D, Rodés-Cabau J
August 29, 2019 | 10.4244/EIJV15I5A73
Interventions for heart failure
Interatrial shunting for heart failure: current evidence and future perspectives
Guimarães L, Lindenfeld J, Sandoval J, Bayés-Genis A, Bernier M, Provencher S, Rodés-Cabau J
June 20, 2019 | 10.4244/EIJ-D-18-01211
Interventions for valvular disease
FORMA Tricuspid Repair System: device enhancements and initial experience
Asmarats L, Philippon F, Bedard E, Rodés-Cabau J
March 20, 2019 | 10.4244/EIJ-D-18-00956
Interventions for valvular disease
First-in-man use of the new-generation TriGUARD 3 cerebral embolic protection device during transcatheter aortic valve implantation
Paradis J, Nazif T, Rodés-Cabau J
December 7, 2018 | 10.4244/EIJ-D-18-00442
Early commercial experience from transcatheter aortic valve implantation using the Portico™ bioprosthetic valve: 30-day outcomes in the multicentre PORTICO-1 study
Maisano F, Worthley S, Rodés-Cabau J, Linke A, Fichtlscherer S, Schäfer U, Makkar R, Fontana G, Asch F, Søndergaard L
October 19, 2018 | 10.4244/EIJ-D-18-00343
Interventions for valvular disease
To nurture a snake in one’s bosom: aspiration of a giant right atrium thrombus after a MitraClip procedure
Paradis J, O’Connor K, Asmarats L, Rodés-Cabau J
October 12, 2018 | 10.4244/EIJ-D-18-00411
Interventions for valvular disease
Effect of size and position of self-expanding transcatheter valve on haemodynamics following valve-in-valve procedure in small surgical bioprostheses: an in vitro study
Zenses A-S, Evin M, Stanová V, Clavel M-A, Barragan P, Rodés-Cabau J, Obadia J, Pibarot P, Rieu R
June 14, 2018 | 10.4244/EIJ-D-17-00875
Interventions for valvular disease
Combined erythropoietin and iron therapy for anaemic patients undergoing transcatheter aortic valve implantation: the EPICURE randomised clinical trial
Urena M, Del Trigo M, Altisent O, Campelo-Parada F, Regueiro A, Delarochelliere R, Doyle D, Mohammadi S, Paradis J, Dagenais F, Dumont E, Puri R, Laroche V, Rodés-Cabau J
May 15, 2017 | 10.4244/EIJ-D-16-00591
Interventions for valvular disease
Transcatheter aortic valve replacement with the Portico valve: one-year results of the early Canadian experience
Perlman G, Cheung A, Dumont E, Stub D, Dvir D, Del Trigo M, Pelletier M, Alnasser S, Ye J, Wood D, Thompson C, Blanke P, Leipsic J, Seidman M, LeBlanc H, Buller C, Rodés-Cabau J, Webb J
January 20, 2017 | 10.4244/EIJ-D-16-00299
Interventions for valvular disease
Transcatheter interventions for tricuspid regurgitation: the FORMA Repair System
Puri R, Rodés-Cabau J
September 18, 2016 | 10.4244/EIJV12SYA31
Interventions for valvular disease
Thirty-day outcomes in patients at intermediate risk for surgery from the SAPIEN 3 European approval trial
Vahanian A, Urena M, Walther T, Treede H, Wendler O, Lefèvre T, Spence M, Redwood S, Kahlert P, Rodés-Cabau J, Leipsic J, Webb J
June 10, 2016 | 10.4244/EIJV12I2A37
Interventions for valvular disease
Managing heart block after transcatheter aortic valve implantation: from monitoring to device selection and pacemaker indications
Urena M, Rodés-Cabau J
September 17, 2015 | 10.4244/EIJV11SWA30
Myocardial injury following transcatheter aortic valve implantation: insights from delayed-enhancement cardiovascular magnetic resonance
Ribeiro H, Larose E, de la Paz Ricapito M, Le Ven F, Nombela-Franco L, Urena M, Allende R, Amat-Santos I, Dahou A, Capoulade R, Clavel M-A, Mohammadi S, Paradis J, De Larochelliere R, Doyle D, Dumont E, Pibarot P, Rodés-Cabau J
June 19, 2015 | 10.4244/EIJV11I2A39
Left atrial decompression through unidirectional left-to-right interatrial shunt for the treatment of left heart failure: first-in-man experience with the V-Wave device
Amat-Santos I, Bergeron S, Bernier M, Allende R, Ribeiro H, Urena M, Pibarot P, Verheye S, Keren G, Yaacoby M, Nitzan Y, Abraham W, Rodés-Cabau J
January 22, 2015 | 10.4244/EIJY14M05_07
Incidence, predictive factors and haemodynamic consequences of acute stent recoil following transcatheter aortic valve implantation with a balloon-expandable valve
Nombela-Franco L, Ribeiro H, Urena M, Pasian S, Allende R, Doyle D, Delarochelliere R, DeLarochelliere H, Laflamme L, Laflamme J, Jerez-Valero M, Cote M, Pibarot P, Larose E, Dumont E, Rodés-Cabau J
April 22, 2014 | 10.4244/EIJV9I12A237

Latest news

AHEAD OF PRINT
Trends and predictors of radiation exposure in percutaneous coronary intervention: the PROTECTION VIII study
FREE ARTICLE - Thomas J. Stocker et al
January 24, 2022
AHEAD OF PRINT
Three-year TAVI outcomes for BAV vs TAV
FREE ARTICLE - Dao Zhou et al.
January 20, 2022
NEW ISSUE
EuroCTO Club Consensus on Dual Lumen Microcatheters for CTO Recanalisation; Predicting Radial Crossover in ACS, the MATRIX score; DAPT duration for BRS; and more…
December 17, 2021
AHEAD OF PRINT
Percutaneous management of left ventricular assist device outflow graft obstruction
FREE ARTICLE - Aleksandra Gasecka et al.
January 19, 2022
AHEAD OF PRINT
Lipid-rich plaque density and LDL-C in statin-treated vs statin-naïve patients
FREE ARTICLE - Rebecca Torguson et al.
January 17, 2022
AHEAD OF PRINT
Redo transcatheter mitral valve replacement in mitral annular calcification
FREE ARTICLE - Jennifer Jdaidani et al
January 13, 2022
AHEAD OF PRINT
TAVI vs SAVR in bicuspid aortic valve stenosis
FREE ARTICLE - Monil Majmundar et al.
January 12, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke